Cargando…
Characterizing the structure–activity relationships of natural products, tanshinones, reveals their mode of action in inhibiting spleen tyrosine kinase
The cytosolic non-receptor protein kinase, spleen tyrosine kinase (SYK), is an attractive drug target in autoimmune, inflammatory disorder, and cancers indications. Here, we employed pharmacophore-based drug screening combined with biochemical assay and molecular dynamics (MD) simulations to identif...
Autores principales: | Tung, Min-Che, Tsai, Keng-Chang, Fung, Kit-Man, Don, Ming-Jaw, Tseng, Tien-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693659/ https://www.ncbi.nlm.nih.gov/pubmed/35424194 http://dx.doi.org/10.1039/d0ra08769f |
Ejemplares similares
-
Unveiling the Mode of Action of Two Antibacterial Tanshinone Derivatives
por: Wang, Dongdong, et al.
Publicado: (2015) -
Role of spleen tyrosine kinase in liver diseases
por: Kurniawan, Dhadhang Wahyu, et al.
Publicado: (2020) -
Targeting Spleen Tyrosine Kinase-Bruton's Tyrosine Kinase Axis for Immunologically Mediated Glomerulonephritis
por: Chen, Jin-Shuen, et al.
Publicado: (2014) -
Discovery of 8-prenylnaringenin from hop (Humulus lupulus L.) as a potent monoacylglycerol lipase inhibitor for treatments of neuroinflammation and Alzheimer's disease
por: Tung, Min-Che, et al.
Publicado: (2021) -
Correction: Discovery of 8-prenylnaringenin from hop (Humulus lupulus L.) as a potent monoacylglycerol lipase inhibitor for treatments of neuroinflammation and Alzheimer’s disease
por: Tung, Min-Che, et al.
Publicado: (2022)